Results of Phase II trial Sorafenib + Dacarbazine

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=77316

If I read correctly, 3 synovial sarcoma patients out of 10 had some benefit...